Millennium Management’s Ocata Therapeutics OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-12,600
Closed -$106K – 3976
2015
Q4
$106K Buy
+12,600
New +$84.3K ﹤0.01% 3235
2015
Q2
– Sell
-51,840
Closed -$319K – 4168
2015
Q1
$319K Buy
+51,840
New +$332K ﹤0.01% 3000

Millennium Management's OCAT Position: Q1 2016 in Review

Millennium Management sold out of Ocata Therapeutics (OCAT) in Q1 2016, closing a stake of 12,600 shares — an estimated $106K sold.

Millennium Management first reported a position in OCAT in Q1 2015 and held it in 2 quarters. The position peaked at $319K in Q1 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Millennium Management reported no remaining Ocata Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Millennium Management sold 12,600 Ocata Therapeutics shares in Q1 2016, an estimated $106K.
  • Millennium Management first reported a position in Ocata Therapeutics in Q1 2015 and held it in 2 quarters.
  • Millennium Management's Ocata Therapeutics position peaked at $319K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Ocata Therapeutics as of Q1 2016.

Based on Millennium Management's 13F filing for Q1 2016, filed 16 May 2016.